Liberty Biopharma Inc (CVE:LTY – Get Free Report)’s stock price passed above its fifty day moving average during trading on Monday . The stock has a fifty day moving average of C$2.00 and traded as high as C$2.00. Liberty Biopharma shares last traded at C$2.00, with a volume of 700 shares traded.
Liberty Biopharma Trading Up ∞
The firm has a market cap of C$21.54 million and a price-to-earnings ratio of -12.66. The company’s 50 day simple moving average is C$2.00 and its 200 day simple moving average is C$2.00. The company has a debt-to-equity ratio of 8.19, a current ratio of 0.12 and a quick ratio of 0.12.
Liberty Biopharma Company Profile
Liberty Biopharma Inc, a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of an automated bioprocessing and cell isolation technology. Its technology is used in the isolation of regenerative cells from human adipose tissues for use in research, cosmetic and aesthetic medicine, burn management, wound management and non-healing wounds, cardiovascular and heart diseases, peripheral arterial disease, critical limb ischemia or diabetic leg, and hepatic disease and kidney disease.
Featured Articles
- Five stocks we like better than Liberty Biopharma
- What is the S&P/TSX Index?
- United Airlines Soars on Earnings Beat
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- J.B. Hunt Hits the Skids: Lower Prices to Come
- Are Penny Stocks a Good Fit for Your Portfolio?
- Predicting a Bear Market: 7 Signs and Why it’s Tough to Do
Receive News & Ratings for Liberty Biopharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Liberty Biopharma and related companies with MarketBeat.com's FREE daily email newsletter.
